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Organophosphorus (OPs) compounds are widely used as insecticides, plasticizers,
and fuel additives. These compounds potently inhibit acetylcholinesterase (AChE), the
enzyme that inactivates acetylcholine at neuronal synapses, and acute exposure to high
OP levels can cause cholinergic crisis in humans and animals. Evidence further suggests
that repeated exposure to lower OP levels insufficient to cause cholinergic crisis,
frequently encountered in the occupational setting, also pose serious risks to people.
For example, multiple epidemiological studies have identified associations between
occupational OP exposure and neurodegenerative disease, psychiatric illness, and
sensorimotor deficits. Rigorous scientific investigation of the basic science mechanisms
underlying these epidemiological findings requires valid preclinical models in which
tightly-regulated exposure paradigms can be correlated with neurotoxicity. Here, we
review the experimental models of occupational OP exposure currently used in the
field. We found that animal studies simulating occupational OP exposures do indeed
show evidence of neurotoxicity, and that utilization of these models is helping illuminate
the mechanisms underlying OP-induced neurological sequelae. Still, further work is
necessary to evaluate exposure levels, protection methods, and treatment strategies,
which taken together could serve tomodify guidelines for improving workplace conditions
globally.
Keywords: neurotoxicity, organophosphorus compounds, organophosphate pesticides, organophosphates,
organophosphate ester pesticides
INTRODUCTION
Organophosphorus chemicals (OPs) were developed in the early 1900s as insecticides that disabled
insects via inhibition of cholinesterases (ChE). While these chemicals were equally as effective
as their predecessor organochlorine pesticides, OPs offered a significant advantage of reduced
environmental persistence (Marrs et al., 2007; Moshiri et al., 2012). Unfortunately, because of the
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conservation of ChEs across species, including human, OPs were
adapted as chemical warfare agents in the 1930s and remain
among the most potent chemical warfare agents used today.
Moreover, intentional ingestion of OP pesticides is the most
common means of suicide in regions of the world where guns
are not widely available (Eddleston et al., 2008). Throughout the
world, however, OPs have primarily been used as insecticides
to protect crops, animals, and humans, and also as industrial
solvents in manufacturing or as fuel additives (Davisson et al.,
2005). For more general information on OPs see: (Pope, 1999;
Costa, 2006; Balali-Mood and Abdollahi, 2014). Because of their
widespread use, OPs are ubiquitous in the global environment,
as evidenced by their detection in rivers, groundwater, soil, air,
plants, animals, and human tissues (Schnoor, 1992; Davisson
et al., 2005; Barr et al., 2011; Clune et al., 2012). Although
ambient exposure to OPs in some parts of the world has declined
due to recent restrictions (Clune et al., 2012), occupational
OP exposures are still prevalent globally, and neurotoxicity has
emerged as one of the primary endpoints of concern (Rohlman
et al., 2011). Continued research is needed to address the
neurotoxicity associated with occupational OP exposures, in
order to determine safe exposure levels, appropriate protection
methods, and promising treatment strategies. Here, we review
in vivo studies that have modeled occupational OP exposure
to determine the impact on the nervous system, as well as in
vitro studies designed to examine molecular pathways relevant
to occupational OP exposure.
The multiple clinical syndromes associated with OPs are
largely determined by the dose, route, and duration of OP
exposure. In this review, we distinguish between the following
types of OP exposure: acute (single exposure or multiple
exposures within 24 h), developmental (in utero or early life
exposures), prolonged/subchronic (exposures of <90 days), and
chronic (>90 days) (Klaassen et al., 2013). Acute OP exposures
that inhibit AChE enzyme activity by 80–90% precipitate
cholinergic crisis via overstimulation of the nervous system
leading to respiratory failure, flaccid paralysis, decreased blood
pressure, parasympathetic discharge, and even death. For reviews
on acute OP exposure (see Sullivan and Blose, 1992; Singh and
Sharma, 2000; Peter et al., 2014). The effects of developmental,
prolonged, and chronic exposures to OPs are less clear, however.
One challenge in studying these types of exposures is their
proper characterization. Currently, AChE activity and personal
reports are the most commonly used methods for assessing OP
exposures. However, baseline AChE activity levels vary greatly,
reductions in AChE activity do not correlate well with reported
symptoms or observed deficits, manifestations of exposure
persist long after ChE levels return to normal, and personal
accounts of exposure may be incomplete (Rohlman et al., 2011,
2016). Fortunately, studies are currently underway to specifically
expand the repertoire of biomarkers for OP exposure (Lein et al.,
2012).
Prolonged or chronic, low- to moderate-level exposures
frequently occur in occupational settings, but also include living
with someone who is occupationally exposed, ingesting
contaminated food, or living near OP application and
manufacturing sites. Numerous occupations result in direct
or indirect OP exposure, including agricultural work and
pesticide manufacturing. Worldwide, billions of pounds of
pesticides are manufactured, transported, and applied yearly,
and individuals working at any stage of pesticide production,
transportation, or application are at risk for OP exposure.
Other individuals at high risk of occupational OP exposure
include exterminators, greenhouse workers and florists, aircraft
personnel exposed to jet fuel and engine oil, veterinarians
exposed while treating animals for pests, and military personnel
exposed during deployment. Each of these occupations
represents a different profile of occupational OP exposure, with
the potential for different neurotoxic outcomes. For reviews
concerning low-level, chronic exposures to OP or chronic
AChE inhibition, (see Steenland, 1996; Brown and Brix, 1998;
Ray, 1998; Ray and Richards, 2001; Kamel and Hoppin, 2004).
Chronic exposures vary widely in duration, route, dose, and
severity of effects. Unfortunately, studies regarding the effects of
these types of exposures in humans are controversial. Though
chronic exposure does not usually induce symptoms associated
with acute cholinergic overstimulation, it is associated with
debilitating neuropsychiatric conditions, such as depression,
anxiety, and suicide (Stephens et al., 1995; Parrón et al., 1996;
Salvi et al., 2003; Stephens and Sreenivasan, 2004; Lee et al., 2007;
Beseler et al., 2008; Freire and Koifman, 2013; Zaganas et al.,
2013; Beard et al., 2014). Furthermore, occupational exposures
are associated with deficits in executive functioning (Fiedler
et al., 1997; Baldi et al., 2003; Farahat et al., 2003; Rohlman
et al., 2007; Ross et al., 2013; Zaganas et al., 2013), increased
prevalence of neurodegenerative diseases, such as Parkinson’s
disease (PD), Alzheimer’s disease (AD), and amyotrophic lateral
sclerosis (ALS) (Mcdowell et al., 1994; Priyadarshi et al., 2001;
Baldi et al., 2003; Alavanja et al., 2004; Santibáñez et al., 2007;
Kanthasamy et al., 2012; Malek et al., 2012; Narayan et al., 2013;
Wang et al., 2014), psychiatric conditions, such as depression,
anxiety, and suicide (Stephens et al., 1995; Parrón et al., 1996;
Salvi et al., 2003; Stephens and Sreenivasan, 2004; Lee et al.,
2007; Beseler et al., 2008; Freire and Koifman, 2013; Zaganas
et al., 2013; Beard et al., 2014; Hardos et al., 2016), and cognitive
deficits (Fiedler et al., 1997; Baldi et al., 2003; Farahat et al.,
2003; Rohlman et al., 2007; Ross et al., 2013). Conversely,
some studies have reported no strong associations between
occupational exposures and neurobehavioral performance
(Starks et al., 2012) or neurodegeneration (Baltazar et al.,
2014; Sánchez-Santed et al., 2016). Furthermore, a recent study
observed no correlation between urinary OP metabolites and
neurobehavioral performance (Krieg, 2013). Interpretation of
the epidemiological findings is complicated by the complexity
of chemical exposures, poor exposure records, problems with
bias and recall in self-reporting, and the fact that some forms of
exposure result in delayed neuropathies that may not manifest
within the timeline of the study. Thus, controlled in vivo and in
vitro studies in preclinical models are important for establishing
cause-effect relationships between OP exposures that simulate
occupational exposure and adverse outcomes relevant to people.
In this review, “human acute exposure” is defined as a
single accidental exposure or multiple exposures within 24 h.
“Human subchronic exposure” is defined as repeated exposures
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over weeks, and “human chronic exposure” is defined as
repeated exposures over months or years. The same criteria
for duration of exposure was applied to the in vivo animal
studies examined here. To assess the current body of literature
reporting effects of prolonged and chronic OP exposures in
preclinical models, we conducted a comprehensive literature
search of the PubMed electronic bibliographic database system
of the National Library of Medicine of the United States using
the following terms without date restrictions: (1) duration of
exposure (chronic, continuous, repeated, prolonged, multiple, or
extended); (2) dose (subthreshold, subcholinergic, subclinical,
low, moderate, or occupational) and route (dermal, topical,
subcutaneous, or inhalation); and (3) OP and the names of
specific OPs (see Table 1). We found that chlorpyrifos (CPF),
diazinon (DZ), dichlorvos (DDVP), diisopropylfluorophosphate
(DFP), malathion, methylparathion (MP), and triorthocresyl
phosphate (TOCP) were the most extensively studied OPs, and
that many studies identified a specific OP as a key search
term without referencing the general class of chemicals. Studies
included in this review and deemed as low to moderate exposures
were prolonged, chronic, or repeated exposures that did not
cause cholinergic crisis or overt signs of toxicity, including
significant changes in weight or ChE inhibition >85%. We
focused on dermal exposure, as this is the dominant route of
exposure in occupational settings (Durham et al., 1972; Sullivan
and Krieger, 1992; Fenske et al., 2012). The rate of dermal
penetration and absorption varies greatly between OP agents,
and the toxicokinetics of OPs absorbed through the skin can
be different from those that occur by other routes of exposure.
Intraperitoneal (IP) injection and oral administration, for
example, achieve higher systemic dosing than dermal exposure
(Ellison et al., 2011). Although inhalation is also a significant
route of occupational exposure, especially when considering
aircraft crew and maintenance workers exposed to TOCP (de Ree
et al., 2014; Hardos et al., 2016), we found a limited number of
published OP inhalation animal studies. Given that it is difficult
to draw meaningful conclusions from so few studies, we did not
review the inhalation route of exposure. Furthermore, in vivo
studies were excluded if exposures occurred during development,
prior to 5 weeks of age formice (Finlay andDarlington, 1995) and
rats (Sengupta, 2013). Finally, we used the percent inhibition of
AChE or ChE as a dosimetric for comparing studies, as many of
these studies indicate blood, cell, or brain region-specific levels
of ChE inhibition. Table 2 (in vivo studies) and Table 3 (in vitro
studies) list the studies included in this review.
NEUROBEHAVIORAL EFFECTS IN
LABORATORY MODELS
Hereafter, we review the neurobehavioral findings of studies
aimed at understanding prolonged or repeated, low- to
moderate-level OP exposure in animal models. We examine OP
effects on learning and memory, attention, impulsivity, motility,
depression, and anxiety. See Table 2 for a summary of the studies
included, and Table 4 for a brief summary of neurobehavioral
findings.
Learning and Memory
Epidemiological studies have linked occupational OP exposure
to deficits in both learning and memory, including self-reported
memory and standardized tasks of information processing
(Farahat et al., 2003; Rohlman et al., 2007; Ismail et al., 2012).
Conversely, some studies have found no association between
occupational OP exposure and learning and memory deficits
(Baltazar et al., 2014; Sánchez-Santed et al., 2016). Accordingly,
researchers have investigated this phenomenon in various in
vivo OP exposure models to better understand the potential
cause-effect relationship.
Multiple behavioral tests can be used to assess learning and
memory in animal models, including the Morris water maze
(MWM), Barnes maze (BM), radial arm maze (RAM), novel
object recognition (NOR), and operant conditioning (OC) tasks
(Vorhees and Williams, 2014; Quillfeldt, 2016). MWM, BM,
and RAM tasks rely on hippocampal function to remember an
escape or reward location based on association with spatial cues.
MWM is more aversive than BM, as the animal must swim
to escape instead of walking on an open platform in search of
the escape hole in the BM. RAM uses a multi-armed platform
to test the animal’s ability to locate a reward on a single arm,
which is indicated by a spatial cue. The NOR task examines
recognition memory by exploiting the propensity of rodents
to spend more time exploring a novel object than a familiar
one. Finally, OC tasks, either passive or active avoidance, use
operant training procedures in which an animal’s response is
learned and elicited based on a predictable aversive stimulus.
Each paradigm has its own set of advantages and disadvantages,
and these characteristics should be carefully considered when
selecting which task to apply in the laboratory. For a review on
the advantages and disadvantages of specific behavior tasks please
see: (Vorhees and Williams, 2014; Quillfeldt, 2016). Described
below are studies that have examined the impact of OP exposure
relevant to occupational exposures in humans on learning and
memory tasks in animal models.
Executive functions of learning and memory are impaired
in humans and rodents following prolonged or chronic, low to
moderate CPF exposure (Farahat et al., 2003; Rohlman et al.,
2007; Ismail et al., 2012). For example, rats exposed to CPF for 14
days at levels producing 30–60% plasma ChE inhibition 24 h after
single injection (2.5, 10, 18, and 25 mg/kg/d) exhibited deficits in
the MWM (Terry et al., 2003). During the learning phase of the
task, rats exposed to CPF at 18 or 25 mg/kg required significantly
longer time to learn the location of the escape platform. Rats
exposed at these levels also exhibited memory deficits, spending
a lower percentage of their time in the target escape quadrant
and crossing the location of the target fewer times than controls
during the probe test of memory. Although swim speeds were
decreased in the high CPF treatment groups, this cannot solely
account for learning and memory deficits as all groups were
able to perform the visible platform task equally. Furthermore,
a second group of rats exposed to 25 mg/kg/d CPF for 14
days, which produced approximately 60% plasmaChE inhibition,
were tested in the MWM following a 14-day washout period
to determine whether the deficits persisted longer than 1 week.
Results showed that CPF-exposed rats performed normally in
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TABLE 2 | In vivo studies included in this review.
Organophosphorous chemical Dosing parameters % ChE reductions Species Publication
Dose (mg/kg) Exposure period
Chlorpyrifos (CPF) 0.1, 1, 10 7 days daily 0–80 in plasma Wistar rats Muller et al., 2014
2.5, 10, 18 30 days every other day 60–80 in plasma Wistar rats Terry et al., 2007
2.5, 5, 10, 20 10 days daily N/A Sprague-Dawley rats Chen et al., 2014
2.5, 10, 18, 25 1–38 days daily 30–60 in plasma Wistar rats Terry et al., 2003
2.5, 30 Once a week for 4 weeks 0–60 in plasma Sprague-Dawley rats Huff et al., 2001
3, 10 21 days daily 90–100 in whole blood Long Evans rats Lee et al., 2016
3, 18 14 days daily 60–80 in brain Wistar rats Hernandez et al., 2015
5 5 days daily 40 in brain C57B1/6J mice Speed et al., 2012
10, 18 30 days every other day 80 in plasma Wistar rats Terry, 2012
10, 20, 40 7 days daily N/A Sprague-Dawley rats Chen et al., 2011
18 14 days daily 70 in plasma Wistar rats Middlemore-Risher
et al., 2010
18 30 days every other day 80 in plasma Wistar rats Middlemore-Risher
et al., 2010
20.2, 40.4 7 days daily 30 in serum Swiss albino mice Lim et al., 2011*
40.4, 101 18 days daily 75–95 in serum Swiss albino mice Mitra et al., 2009*
Dichlorvos (DDVP) 1, 6 84 days daily 10–55 in serum Wistar rats Verma et al., 2009
2.5 84 days daily 0 in brain Wistar rats Binukumar et al., 2010
2.5 84 days daily N/A Wistar rats Binukumar et al., 2011
6 84 days daily N/A Wistar rats Kaur et al., 2007
Diisopropylfluorophosphate (DFP) 0.05, 0.25, 0.5 14 days daily 50 in brain Wistar rats Prendergast et al., 1997
0.1, 0.2 21 days daily 50–75 in brain Long Evans rats Bushnell et al., 1991
0.2, 0.4 5 days a week for 4 weeks 70–85 in brain Long Evans rats Mundy et al., 1993
0.25 14 days daily N/A Wistar rats Prendergast et al., 1998
0.25 14 days daily 50–60 in brain Wistar rats Stone et al., 2000
0.25, 0.5, 0.75, 1.0 30 days every other day 55–80 in plasma Wistar rats Terry et al., 2011
0.25, 0.75 30 days every other day 75 in plasma Wistar rats Terry, 2012
0.5 30 days every other day 40 in plasma Wistar rats Terry et al., 2014
0.8 3 days a week for 4 weeks 70–85 in brain Long Evans rats Mundy et al., 1993
Malathion 30, 100 15 days daily 0–40 in brain Swiss albino mice dos Santos et al., 2016
Methyl Parathion (MP) 0.1, 1 95 days daily 3–64 in brain Sprague-Dawley rats Ma et al., 2003*#
2 10 days daily 30 in plasma Wistar rats Castillo et al., 2002
3 21 days daily 80–90 in brain Sprague-Dawley rats Sun et al., 2003
3 21 days daily 80 in brain Sprague-Dawley rats Sun et al., 2006
*Indicates route of exposure other than SC (topical or tail patch); # Indicates test subjects were female.
the MWM, indicating that CPF-induced deficits in this exposure
paradigm were transient (Terry et al., 2003). Interestingly, longer
CPF exposure paradigms cause greater suppression of plasma
ChE over time, but similar deficits in MWM. Rats exposed to
CPF at 18 mg/kg every other day for 30 days exhibited 80%
plasma ChE inhibition and deficits in MWM following a 7-day
washout period (Terry et al., 2007). Even more severe and longer
lasting deficits in learning and memory have been observed in
both a modified RAM and MWM following prolonged exposure
of rats to CPF. For example, exposure at 10 and 18 mg/kg CPF
every other day for 30 days, causing plasma ChE suppression
by up to 80%, resulted in RAM and MWM deficits even after
prolonged washout periods of 50 and 140 days, respectively
(Terry et al., 2012). Taken together, these studies support CPF-
induced alterations in learning and memory, with length of
exposure influencing the persistence of the deficit. Of note, these
studies were performed in the same laboratory, and results would
be strengthened with confirmation by an independent laboratory.
Although DDVP has not been as extensively studied as CPF,
one study supports an effect of this agent on learning and
memory. Specifically, animals exposed to DDVP daily for 12
weeks at 1 and 6 mg/kg/d, producing 10–55% reductions in
serum ChE and 20–80% reductions in brain AChE, performed
significantly worse in a dose-dependent manner on MWM and
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TABLE 3 | In vitro studies included in this review.
OP In vitro/Ex vivo model system Exposure parameters % ChE
reductions
Publication
Concentration (µM) Exposure period
Chlorpyrifos (CPF) Primary Culture (superior cervical ganglia) 0.0001, 0.001, 0.01,
0.1, 1, 10
24 h ≤90 Howard et al., 2005
Primary Culture (dorsal root ganglia) 0.01, 0.1, 1, 10 (CPF);
0.01, 0.1, 1, 10 (CPO)
24 h ≤75 Yang et al., 2008
BMEC; Primary Culture (astrocytes) 0.01, 0.1, 1, 10, 100,
1000, 10,000
24 h 40–100 Parran et al., 2005
PC12 (rat adrenal pheochromocytoma cell line) 0.1, 1, 10, 50 (CPF,
CPO)
20 min 0 (CPF); ≥50
(CPO)
Meijer et al., 2014
PC12 (rat adrenal pheochromocytoma cell line) 0.1–100 24 h N/A Meijer et al., 2015
Hippocampal Slice Cultures 0.1, 1, 10 (CPO) 1, 3, or 7 days ≤50 Prendergast et al.,
2007
Primary Culture (cortical neurons) 1, 5, 10, 20 (CPF, CPO) 1 or 24 h 0–50 (Middlemore-Risher
et al., 2011)
Primary Culture (cortical neurons) 100 (CPF); 1, 10, 30,
100 (CPO)
24 h 80–90 Rush et al., 2010
PC12 (rat adrenal pheochromocytoma cell line) 30 1–3 days N/A Slotkin and Seidler,
2010
Isolated kinesin and microtubules 1, 10 20 min N/A Gearhart et al., 2007
Isolated tubulin and microtubules 5, 10, 25, 50, 100 24 h N/A Grigoryan and
Lockridge, 2009
Human fetal primary astrocytes 0, 25, 50, 100 14 days, 7 days apart N/A Mense et al., 2006
Diazinon (DZ) Isolated synaptosomes 0.00000001-0.001
(DZ, DZO, IMP)
1 h ≤95 Colovic et al., 2015
Primary Culture (cortical astrocytes/hippocampal
neurons)
0.1, 1, 10 (DZ,DZO) 24 h 50–80 Pizzurro et al.,
2014a
Primary Culture (cortical astrocytes/hippocampal
neurons)
0.1, 1, 10 (DZ,DZO) 24 h 20 in
astrocytes
Pizzurro et al.,
2014b
Primary Culture (cortical neurons) 1, 10, 30, 100 (DZ,
DZO)
24 h ≤90 Rush et al., 2010
PC12 (rat adrenal pheochromocytoma cell line) 30 1–3 days N/A Slotkin and Seidler,
2010
Diisopropylfluorophosphate
(DFP)
Primary Culture (cerebral cortices) 0.0001, 0.001, 0.01,
0.1, 1
24 h N/A Gao et al., 2016
Isolated kinesin and microtubules 0.0001, 0.0059 20 min N/A Gearhart et al., 2007
Malathion RBE4 cells 0.00001 (malathion);
0.000001 (malaoxon)
2, 4, 8, 16, and 26 h N/A Balbuena et al.,
2011
RBE4 cells; BMEC 0.01, 0.1, 1, 10, 100,
1000
24 h 30–80 Balbuena et al.,
2010
Parathion Primary Culture (hippocampal neurons) 30, 40, 50, 100 (POX) single dose for 3 weeks N/A Yousefpour et al.,
2006
Primary Culture (hippocampal neurons) 0.3, 3, 30, 300 (POX) ≤1 h N/A Rocha et al., 1996
PC12 (rat adrenal pheochromocytoma cell line) 3, 10, 50 20 min ≤50 Meijer et al., 2014
Primary Culture (differentiating neural and stem
progenitors)
16, 30, 50, 66, 100,
150, 200, 300 (POX)
6 days ≤50 Berríos et al., 2015
Tri-ortho-cresyl phosphate
(ToCP)
Primary Culture (corticol neurons) 0.001, 0.01, 0.1, 1, 10 24 h N/A Hausherr et al.,
2014
Primary Culture (corticol neurons) 10 24 h N/A Hausherr et al.,
2016
Primary Culture (corticol neurons) 10 48 h 0 Duarte et al., 2016
SH-SY5Y (human derived neuroblastoma cell line) 200, 500, 1000 24 h N/A Chen et al., 2013
BMEC, bovine brain microvascular endothelial cell line; RBE4, rat brain microvascular endothelial cell line.
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TABLE 4 | Summary of behavioral studies included in this review.
Behavioral domain OP Behavioral outcome Species Publication
Learning and memory CPF Deficit (MWM) Wistar rats Terry et al., 2003
Deficit (MWM) Wistar rats Terry et al., 2007
Deficit (MWM and RAM) Wistar rats Terry, 2012
DDVP Deficit (MWM and OC passive avoidance) Wistar rats Verma et al., 2009
DFP Deficit (OC) Long Evans rats Bushnell et al., 1991
Deficit (MWM) Wistar rats Prendergast et al., 1997
Deficit (MWM); No Deficit (recall) Wistar rats Prendergast et al., 1998
Deficit (MWM) Wistar rats Stone et al., 2000
Deficit (MWM and NOR) Wistar rats Terry et al., 2011
Deficit (MWM); No Deficit (RAM) Wistar rats Terry, 2012
MP Deficit (MWM) Wistar rats Castillo et al., 2002
No Deficit (OC active avoidance) Sprague-Dawley rats Sun et al., 2006
Malathion Deficit (NOR) Swiss albino mice dos Santos et al., 2016
Attention and impulsivity CPF Deficit (5C-SRTT) Wistar rats Middlemore-Risher et al., 2010
DFP Deficit (5C-SRTT) Wistar rats Terry et al., 2014
Motility and motor coordination CPF Deficit (grip strength) Wistar rats Terry et al., 2003
No Deficit (activity) Sprague-Dawley rats Chen et al., 2014
DDVP Deficit (grip strength and motor coordination) Wistar rats Verma et al., 2009
Deficit (activity) Wistar rats Binukumar et al., 2010
DFP Deficit (activity) Long Evans rats Bushnell et al., 1991
Deficit (activity) Wistar rats Prendergast et al., 1997
Deficit (grip strength); No Deficit (motor coordination) Wistar rats Terry et al., 2011
MP Deficit (activity and motor coordination) Sprague-Dawley rats Sun et al., 2006
Depression and anxiety CPF Deficit (exploration) Wistar rats Terry et al., 2003
Deficit (exploration) Wistar rats Terry et al., 2007
Deficit (FST, EPM and novelty-suppressed feeding) Sprague-Dawley rats Chen et al., 2011
Deficit (FST and learned helplessness) Sprague-Dawley rats Chen et al., 2014
DDVP Deficit (exploration) Wistar rats Binukumar et al., 2010
DFP Deficit (exploration) Wistar rats Prendergast et al., 1998
Deficit (exploration) Wistar rats Stone et al., 2000
Deficit (exploration) Wistar rats Terry, 2012
5C-SRTT, 5 choice- serial reaction time test; CPF, chlorpyrifos; DDVP, dichlorvos; DFP, diisopropyl-fluorophosphate; EPM, elevated-plus maze; FST, forced swim task; MP, methyl
parathion; MWM, Morris water maze; NOR, novel object recognition; OC, operant conditioning; RAM, radial arm maze.
OC passive avoidance tasks (Verma et al., 2009). It is possible
that MWM learning deficits could be attributed to deficits in
locomotor activity, as indicated by deficient performance in the
rotatod task. However, deficient motor activity is less likely to
influence the outcome of the passive avoidance OC task, in which
animals still displayed cognitive deficit. Interestingly, although
exposure to DDVP for 12 weeks at 1 mg/kg/d produced learning
and memory deficits, it did not produce significant decreases
in ChE activity, while exposure to the higher DDVP dose did.
These findings suggest that DDVP may cause behavioral deficits
independent of AChE inhibition.
DFP, a highly toxic OP with a relatively low LD50 (refer
to Table 5), induces learning and memory deficits in rodent
exposure models at doses that do not trigger cholinergic crisis.
For example, Bushnell et al. observed cognitive deficits in rats
repeatedly exposed to 0.1 or 0.2 mg/kg DFP for 21 days,
yielding approximately 75% reductions in AChE activity in
the hippocampus and prefrontal cortex but unaccompanied
by cholinergic crisis or overt toxicity (Bushnell et al., 1991).
DFP-exposed animals performed poorly relative to controls
in OC testing with choice and matching accuracy, indicating
impaired learning and memory. However, the authors also
observed significant impairment of mobility in animals exposed
to DFP, which complicates interpretation of performance in
this behavioral learning task. After a 3–4 week washout period,
behavioral deficits were not observed and mobility also returned
to normal, demonstrating reversibility of the toxicity. In addition,
rats exposed to 0.05 and 0.25mg/kg/dDFP for 14 days, producing
up to approximately 50% AChE enzyme activity inhibition in
the hippocampus and frontal cortex, exhibited learning and
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memory deficits in the MWM in a dose-dependent manner
(Prendergast et al., 1997). Effects on learning and memory
are further supported by a subsequent study in which rats
exposed to DFP at 0.25 mg/kg/d for 14 days exhibited spatial
learning and memory deficits in the MWM (Prendergast et al.,
1998). Interestingly, long-term recall learning (or relearning) in
subsequent MWM testing was not impaired, and neither was
performance in delayed discrimination testing, a form of OC
learning. In another study by Terry et al. (2011), DFP-exposed
rats demonstrated impairment in the MWM and NOR tasks
following 0.25, 0.5, and 0.75 mg/kg DFP exposure every other
day for 30 days, producing roughly 55–80% reductions in plasma
ChE activity. However, DFP exposure did not elicit sensorimotor
deficits following a 13-day washout period, as measured by
auditory startle response (ASR) task and prepulse inhibition
(PPI) (Yeomans, 1995). These measurements are used to gauge
a phenomenon in which a weaker prepulse (stimulus) inhibits
the reaction to a subsequently stronger pulse (stimulus), and
serve as commonly used correlates of pre-attentive stages of
information processing. Persistent effects of this type of exposure
were observed in another study in which exposure to 0.75 mg/kg
DFP every other day for 30 days, producing up to 75% reductions
in plasma ChE activity and 85% reductions in brain ChE activity,
produced deficits in theMWM that persisted following a 140-day
washout period (Terry, 2012). However, a similar effect of DFP
exposure on the RAM was not observed, for reasons that remain
unclear.
While MP exposure has been strongly linked to
carcinogenicity and peripheral axonopathy, studies also indicate
MP’s potential to induce cognitive deficits. For example, exposure
to MP at 2 mg/kg/d for 10 days reduced plasma ChE activity by
30% and induced learning deficits in the MWM in rats (Castillo
et al., 2002). Further examination of MP-induced learning
deficits by Sun et al. (2006), however, found that exposure of
rats to 3 mg/kg/d MP for 21 days reduced brain region-specific
ChE activity by up to 80%, yet produced no deficits in OC active
avoidance conditioning. In this task, an animal is conditioned
to respond to aversive stimuli, generally in the form of sound
accompanied by delayed foot shock. Movement of the animal to
a safe location to avoid the shock following the sound indicates
learning (Zovkic and Sweatt, 2013). Exposed animals were not
impaired in either learning or memory. Discrepancies between
these two studies pertaining to the cognitive effects of MP could
be related to differences in behavioral testing, but are unlikely
to involve the duration or dose of exposure, both of which were
lower in the study conducted by Castillo et al. (2002).
Finally, repeated, low- to moderate-level malathion exposure
can also produce learning and memory deficits with minimal
brain AChE inhibition. Specifically, exposure to malathion for 15
days at 30 and 100 mg/kg/d, causing 40% hippocampal AChE
inhibition after 15 days with 100 mg/kg/d dosing, produced
deficits in the object location task, a modified NOR task that
depends on the spatial memory of the animal (dos Santos
et al., 2016). Exposed rats spent significantly less time with
the displaced object than controls, indicating acquisition of
memory deficits, which was observed in the absence of changes
in exploratory behavior or locomotive activity.
In conclusion, a substantial body of literature indicates that
OP exposure is associated with deficits in cognition, as studies
have shown impairments in both learning and memory aspects
of behavioral tasks. Thus, OP exposure appears to disrupt both
acquisition of skills as well as expression of retention of these
learned skills.
Attention and Impulsivity
In addition to learning and memory impairments,
epidemiological evidence suggests that OP exposure may
induce changes in attention and impulsive behavior in adults
(Farahat et al., 2003; Rohlman et al., 2007; Ismail et al., 2012;
Meyer-Baron et al., 2015;Muñoz-Quezada et al., 2016). Attention
and impulse control are critical aspects of executive function
that play fundamental roles in information processing and
are also impaired in numerous psychiatric disorders. Deficits
in attention and impulsive behavior have been observed in
animal models of repeated, low to moderate OP exposures. For
example, Middlemore-Risher et al. (2010) observed disturbances
in sustained attention of rats exposed every day for 14 days, or
every other day for 30 days, to 18 mg/kg of CPF, reducing plasma
ChE by approximately 70–80% and brain region-specific AChE
by 25–60% at the final day of exposure (Middlemore-Risher et al.,
2010). The authors reported increased impulsivity, as measured
by the five Choice-Serial Reaction Time Task (5C-SRTT) that
requires the test subject to correctly identify a temporarily
illuminated opening in order to receive a reward. The length of
time in which the opening is illuminated influences the required
attention and impulse control of the test subject (Hayward
et al., 2016). In support of attention impairments, deficits in PPI
were also observed in CPF-exposed groups (Middlemore-Risher
et al., 2010). Interestingly, PPI deficits appeared to be transient
following a 30-day washout under both the 14- and 30-day
exposure paradigms. Following the washout period, plasma
ChE returned to 80 and 89% of normal, respectively, and brain
AChE activity returned to normal in every region tested for both
exposure paradigms, except in the striatum and basal forebrain.
Studies have also shown that DFP can influence attention and
impulsive behavior. Rats exposed to 0.50 mg/kg DFP every other
day for 30 days, inducing 40% plasma ChE activity inhibition at
the end of the exposure period, exhibited impaired accuracy in
the 5C-SRTT (Terry et al., 2014). Furthermore, these exposures
increased the number of premature, and therefore impulsive,
responses to the challenge as well as timeout responses taking
place after incorrect or premature responses. These effects were
greatest during the exposure period, but still modestly present
after a 45-day washout period (Terry et al., 2014). Interestingly,
previous studies using this same exposure paradigm (every other
day for 30 days) at 0.25, 0.50, 0.75, and 1.0 mg/kg DFP did
not produce deficits in PPI following a 13-day washout (Terry
et al., 2011). These results are consistent with the findings by
Middlemore-Risher et al. (2010) regarding the transient effects
of CPF on attention.
Motility and Motor Coordination
A common manifestation of acute OP exposure in humans is
organophosphate ester-induced delayed neuropathy (OPIDN).
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OPIDN is associated with the ability of OPs to inhibit neuropathy
target esterase (NTE), an alternative OP-target to AChE. OPIDN
can occur with or without cholinergic crisis and other acute
toxicities, as well as in the case of some chronic exposures, and
is characterized by degeneration of distal portions of long axons
within 1–4 days of exposure. Clinical manifestations of OPIDN
include weakness, alterations in reflexes, limb tingling, loss of
sensation, and impairments in locomotion and coordination
(Richardson, 1995; Jamal, 1997; Lotti andMoretto, 2005). Several
OPs have been linked to movement and coordination deficits
in humans following occupational exposures, including CPF,
DFP, DDVP, parathion, and TOCP (Lotti and Moretto, 2005;
Ehrich and Jortner, 2010). Here, we discuss the laboratory
evidence concerning OPs and induced neuropathies or motor
and coordination deficits at low to moderate, repeated exposures.
Studies conducted by Sun et al. (2006) revealed motor deficits
in rat exposed to sub-lethal levels of MP, an OP known to
induce neuropathies in humans. Rats administered 3 mg/kg/d
MP for 21 days exhibited brain region-specific ChE activity
reductions by 80% and showed decreases in basal locomotor
activity. These deficits included decreases in total distance
traveled, vertical activity, ambulation time, and stereotyped time.
Furthermore, exposed animals displayed poorer performance on
rotarod testing, which assesses fine motor coordination. It should
be noted, however, that although exposure to MP at these levels
did not produce overt cholinergic toxicities, animals did manifest
early signs of cholinergic crisis, including purposeless chewing
and irritability.
Rats exposed daily to 0.25 mg/kg DFP for 14 days, which
produced 50% AChE activity inhibition in the hippocampus
and frontal cortex, exhibited disturbances in spontaneous
locomotion during open field testing (Prendergast et al.,
1997). Interestingly, rats exhibited hyperactivity following
exposure to lower levels (0.05 mg/kg/d) of DFP (AChE
activity not measured), but conversely exhibited significant
decreases in activity following exposure to higher DFP doses
(0.25 mg/kg/d). Animals did not exhibit overt cholinergic
crisis during either exposure. Furthermore, Terry et al.
(2011) described deficits in the grip strength of rats exposed
repeatedly to 1.0 mg/kg/d DFP, a dose that produced up
to 80% plasma ChE inhibition. These effects appeared to be
transient, as animals regained grip strength following a 14-
day washout period. No exposure-related deficits in rotarod
performance were observed. Finally, Bushnell et al. (1991)
described reversible motor deficits in rats exposed to 0.1 and
0.2 mg/kg/d DFP for 21 days, causing 50–75% reductions
in AChE activity in the hippocampus and prefrontal cortex.
These deficits were assessed by locomotor activity in a delayed
matching-to-position task, a learning and memory task that
requires substantial locomotor activity (Rothblat and Kromer,
1991).
Chronic exposure to DDVP at 1 and 6 mg/kg/d for 12
weeks, producing 10–55% reductions in serum ChE and 20–
80% reductions in brain AChE activities, significantly impaired
motor coordination and muscle strength in rats (Verma et al.,
2009). DDVP-exposed groups performed significantly worse than
controls on rotarod testing. These findings were reproduced by
exposing rats to 2.5 mg/kg/d DDVP for 12 weeks, producing
no significant reductions in substantia nigra or corpus striatum
brain AChE activity (Binukumar et al., 2010). DDVP-exposed
rats exhibited decreased locomotor activity in open field analysis
at 6 and 12 weeks, asmeasured by decreased distance traveled and
increased immobile time. Again, DDVP-exposed rats performed
poorer during rotarod testing when compared to controls at 6
and 12 weeks (Binukumar et al., 2010).
In addition, Terry et al. (2003) described deficits in rat
hindlimb, and to a lesser extent forelimb, grip strength after
exposure to 2.5 mg/kg/d CPF for 38 days, which produced 30%
plasma ChE inhibition 24 h following a single injection. Here,
ChE levels were not measured at the end of the exposure period.
Effects on grip strength were abated during a 5-day washout
period, and animals appeared normal on day 6. Conversely, no
deficits in motor activity were observed when adolescent rats
(postnatal day 27–36) were exposed to 2.5, 5, 10, or 20 mg/kg/d
CPF for 10 days, indicating that longer exposure periods may be
required to induce deficits in motility (Chen et al., 2014).
Depression and Anxiety
Some epidemiological studies suggest that occupational
exposures to OPs induce changes in the emotional state
of individuals, based on correlations between occupational
exposures and depression, anxiety, and suicide (Parrón et al.,
1996; Lee et al., 2007; Beseler et al., 2008; Freire and Koifman,
2013; Beard et al., 2014). A meta-analysis conducted in 2013 on
occupational exposure and psychiatric issues, however, suggests
these epidemiological studies are limited and inconclusive
(Freire and Koifman, 2013). In vivo studies examining these
endpoints in preclinical models are challenging to interpret,
as emotional affect is not known to be exhibited by rodents.
Instead, preclinical models constitute rodent behavioral
outcomes related to human behaviors driven by the affective
state. Thus, behavioral tasks such as elevated-plus maze (EPM),
novelty-suppressed feeding test, Porsolt forced swim task (FST),
learned helplessness, and exploratory behavior offer behavioral
correlates of human depression and anxiety (Bailey and Crawley,
2009). In the EPM, animals are allowed to explore an elevated
maze containing two closed (protected) arms and two open
(unprotected) arms. Animals spending higher percentages of
time on the open arms are either considered hyperactive or to
be participating in risky behaviors, while animals not exploring
the open arm are considered to be exhibiting anxiety-like
or risk-aversive behaviors. Novelty-suppressed feeding relies
on the fact that a novel environment can suppress feeding
behaviors in rodents. Following a restricted feeding paradigm,
the animal is placed into a novel environment and given
the choice to explore the center of an arena where food is
located. Animals that are reluctant to ambulate to the food
are considered to exhibit anxiety-like behaviors. The FST and
learned helplessness tasks more specifically measure depression-
like phenotypes, and both tasks rely on the efforts of the
animal to escape a stressful situation (Yan et al., 2010). Finally,
exploratory behavior can be examined in almost all of the
above-described tasks, and is dependent on affect (Yan et al.,
2010).
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Adolescent rats (postnatal day 29) exposed to CPF for 7
consecutive days to 10, 20, and 40 mg/kg/d showed alterations in
affect-related behavior (Chen et al., 2011). Animals treated with
10 and 20 mg/kg/d CPF did not exhibit any differences in the
EPM when compared to control animals, but 40 mg/kg/d CPF
was sufficient to induce the risky behavior of more time spent
on the open arm of the EPM. In addition, animals exposed to
10 mg/kg/d CPF showed an increase in immobility time in the
FST, while 20 and 40 mg/kg/d doses did not induce changes in
behavior. Finally, all exposures to CPF in this paradigm resulted
in deficits in the novelty-suppressed feeding task, indicating
anxiety-like behavior (Chen et al., 2011). Unfortunately, ChE was
not measured in this study, and because the exposure paradigm
was shorter and the rats were adolescent, it is difficult to relate
this study to others. However, an additional study examined
the depression-like phenotype of adolescent rats (postnatal day
27–36) exposed to 2.5, 5, 10, or 20 mg/kg/d CPF for 10 days
(Chen et al., 2014). Here, the 10 mg/kg/d CPF exposure increased
immobility in FST, while 5, 10, and 20 mg/kg/d CPF exposures all
induced increased escape failures in the learned helplessness task,
indicating greater susceptibility to depression-like phenotypes.
Importantly, these CPF-induced changes in behavior were not
accompanied by deficits in locomotor activity. Again, ChE was
not reported, making it difficult to relate this study to previously
discussed studies. However, the CPF doses were comparable to
those used by Terry et al. (2003), which produced 30–60% plasma
ChE inhibition 24 h following 2.5, 10, 18, and 25 mg/kg single
injections (Terry et al., 2003).
Finally, exploratory behavior, such as distance traveled,
sniffing, rearing, and forward elongation of the head can be used
to assess the animal’s general well-being, and is thus thought
to correlate to human affective experience (Harro, 1993). It
has been repeatedly shown that in nonthreatening scenarios,
animals spend more time moving throughout the environment
interacting with unfamiliar objects. By contrast, an animal placed
in a threatening scenario will typically exhibit freezing behavior
or cower in a single position. Accordingly, exploratory behavior
has been used to describe innate behavioral movements, fear
responses, brain injury, and response to various pharmacological
agents (Harro, 1993).
Rats exposed to DFP at 0.25 mg/kg/d for 14 days exhibited
decreased rearing and sniffing exploratory activity (Prendergast
et al., 1998). DFP-exposed animals exhibited tolerance after a
week of testing, at which point their exploratory behavior was
comparable to controls. Furthermore, deficits in vertical and
horizontal activity were observed in open field analysis of animals
exposed to 0.75 mg/kg/d DFP every other day for 30 days,
producing up to 75% reductions in plasma ChE activity and 85%
reductions in brain ChE activity (Terry et al., 2012). Other OPs
also alter exploratory behavior. For example, CPF exposure at 2.5,
10, 18, and 25 mg/kg/d for 14 days reduced plasma ChE from 30
to 60% following a single injection and also produced decreases
in sniffing and rearing behaviors (Terry et al., 2003). Additionally,
12 weeks of exposure to 2.5 mg/kg/d DDVP resulted in no
significant ChE inhibition in the brain and produced decreases
in rearing behaviors during open field analysis when compared to
controls (Binukumar et al., 2010). Conversely, 15-day malathion
exposure at 30 and 100 mg/kg/d caused 40% hippocampal AChE
inhibition and did not produce changes in exploratory activity, as
measured by rearings in the open field (dos Santos et al., 2016).
MECHANISMS OF CHRONIC OP
NEUROTOXICITY
The molecular mechanisms by which chronic exposure to OPs
causes neurobehavioral deficits remain speculative. It is well-
established that OPs phosphorylate the active site of AChE
to inhibit its enzymatic activity, resulting in accumulation
of synaptic acetylcholine and altered cholinergic signaling.
However, not all OPs precipitate the same clinical manifestations,
and several OPs also induce symptoms that do not correlate
with AChE inhibition (Pope, 1999; Costa, 2006; Rohlman
et al., 2011). Therefore, it is widely postulated that targets in
addition to AChE are involved in OP-induced neurotoxicity.
For a full review on potential noncholinergic molecular targets,
(see Pope, 1999; Costa, 2006; Jett and Lein, 2006; Terry,
2012). Furthermore, tolerance to AChE enzyme inhibition
is often achieved with prolonged exposure due to down-
regulation of muscarinic and nicotinic acetylcholine receptors
linked to overstimulation of cholinergic pathways (Schwab
et al., 1981; Albuquerque et al., 1985; Bushnell et al., 1991,
1993). In order to more completely understand the molecular
underpinnings of OP-induced neurobehavioral deficits, various
reductionist models have been exploited to study the molecular
effects of OPs in relevant cell types. Some studies have also
investigated molecular changes following in vivo exposures,
and attempted to correlate these findings with behavioral
outcomes. Here, we summarize studies that examine the
effects of OP exposures that do not induce overt toxicity
or significantly inhibit ChE activity in isolated tissue or
cell culture systems. We also summarize published attempts
to reproduce prolonged, low- to moderate-dose occupational
exposure parameters in vitro, as well as in vivo studies that
investigate potential molecular mechanisms of neurotoxicity.
These findings are presented with respect to the following
six categories of molecular mechanisms of OP neurotoxicity:
cytotoxicity, aberrant neuronal cytoarchitecture, aberrant energy
homeostasis, aberrant neurotransmission, neuroinflammation,
and impairment of the blood brain barrier. See Table 6 for a
summary of the following findings.
Cytotoxicity
Many studies have demonstrated that OPs induce neuron damage
or death at levels that do not ablate ChE activity. Cytotoxic effects
are concentration-dependent, and in certain cases, such as CPF
or parathion, differentially mediated by the parent compound vs.
the metabolite. For example, 0.1, 1, and 10µMchlorpyrifos-oxon
(CPO), a CPF metabolite that is a potent ChE inhibitor, produces
neuronal injury in the CA1 and CA3 regions of the hippocampus
(Prendergast et al., 2007). Hippocampal slice cultures treated
with CPO at levels that reduced hippocampal AChE activity by
50% after 3 and 7 days of exposure also exhibited neuronal injury
that was both concentration- and time-dependent, as measured
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TABLE 5 | LD50 (dose lethal to 50% of the test sample) information for selected OPs.
OPs and LD50s
OP Mouse Oral LD50 (mg/kg) Mouse Dermal LD50 (mg/kg) Rat Oral LD50 (mg/kg) Rat Dermal LD50 mg/kg Toxicity in Humans
Acephate 361A 1030–1447A ModerateB
Azinphos-methyl 8–20C 65C 4C 88–220C HighB
Chlorpyrifos 60D 200D 96–270D >2000E ModerateB
Diazinon 80–135F 300–1250G ModerateB
Dichlorvos 61–175C,H 206C 50<500C,H 70.4–250C,H ModerateB
Dimethoate 160C 30–330I 100–2000C,I Moderate B
Disulfoton 2–12J 3.6–15.9J HighB
Ethoprop 61.5K ModerateB
Fenamiphos 22.7H 2–24.8H 72–154H HighB
Malathion 400–4000C 1000–5500C >4000C LowB
Methamidophos 16–21G 50G HighB
Methidathion 18–25C,G 25–54C,G 85–94C,G ModerateB
Methyl Parathion 14.5–19.5C,G 1200C,G 6–50C,G 67C,G HighB
Naled 330–375D 91–430D 800D ModerateB
Oxydemeton-methyl 50L 85L ModerateB
Phorate 2.25–6.59C 1.1–4C 2.5–6.2C,G HighB
Phosmet 23.1–50.1M 113–316M ModerateB
Profenofos 298N 358–1178N 300–2000N ModerateB
AWorthing et al., 1987.
BRoberts and Reigart, 2013.
CGallo and Lawryk, 1991.
DMeister, 1992.
ERacke, 1992.
FWorld Health Organization, 2009.
GKidd and James, 1991.
HU.S. Public Health Service, 2016.
ICheminova Agro A/S, 1991.
JU.S. Environmental Protection Agency, 1984.
KPowers, 1965.
LSax, 1984.
MFood and Agriculture Organization of the United Nations, 1978.
NFood and Agriculture Organization of the United Nations, 2011.
by propidium iodide fluorescence (PI), a polar fluorescent dye
that penetrates damaged cell membranes to bind to nucleic
acids within the cell (Zimmer et al., 2000). CPF exposure at
100 µM and CPO exposure at 1, 10, 30, and 100 µM induced
neuronal injury via excitotoxic mechanisms (Rush et al., 2010).
In this cortical culture system, 100 µM CPF inhibited AChE
by 80%, and 1, 10, 30, and 100 µM CPO inhibited AChE by
80–90%, after 24 h. Pharmacologic antagonism of glutamate
receptors significantly attenuated the neurotoxic effects of CPF
and CPO, suggesting that CPF induces excitotoxic neuronal
death. Subchronic CPF exposure also decreases neuron density
in vivo. Mice exposed topically for 18 days to 40.4 and 101
mg/kg CPF, which produced 75–95% serum ChE inhibition
and 55% brain AChE inhibition (40.4 mg/kg/d produced no
significant brain AChE inhibition), showed dose-dependent
decreases in hippocampal neuron cell counts (Mitra et al., 2009).
When CPF-exposed mice were concomitantly stressed by 6
min of forced swimming in 38◦C water, not only was AChE
inhibition exacerbated, but greater reductions in hippocampal
neuron cell counts were noted as well. In addition, when mice
were topically exposed to 20.2 and 40.4 mg/kg/d CPF for 7
days, which inhibited serum ChE by 30%, significant decreases
in hippocampal neuron cell density and increased astrocyte
reactivity (only at 40 mg/kg/d) were apparent (Lim et al., 2011).
Interestingly, concurrent stress exposure of 6 min of forced
swimming in 38◦C water did not exacerbate the effects of CPF
exposure in this study. The authors suggest that shorter exposure
time and lower doses of exposure could be responsible for the
discrepancy in stress exacerbation between the two studies (Lim
et al., 2011).
DZ (Rush et al., 2010), parathion (Yousefpour et al., 2006;
Berríos et al., 2015), and DDVP (Binukumar et al., 2010;
Binukumar and Gill, 2010) have also been shown to induce
cytotoxicity following exposures that do not inhibit ChE activity
in vitro, or exposures that do not cause overt toxicity in vivo.
DZ produced neuronal cell death in primary cortical neurons
following 24 h of exposure to 30 and 100 µM, resulting
in approximately 50% AChE inhibition (Rush et al., 2010).
Interestingly, no cell death was observed following exposure
of primary cortical neurons to levels of the DZ metabolite
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TABLE 6 | Summary of molecular and cellular endpoints altered by OPs in experimental models of occupational organophosphate exposure.
Endpoint OP Direction of change Model system Publication
Cytotoxicity (1) Cell death (unspecificed) CPF : In vivo (Wistar rats) Prendergast et al., 2007
DZ : In vitro (primary culture) Rush et al., 2010
Parathion : In vitro (primary culture) Berríos et al., 2015
DDVP : In vivo (Wistar rats) Binukumar et al., 2010
: In vivo (Wistar rats) Binukumar et al., 2011
Cell death (apoptotic) DDVP : In vivo (Wistar rats) Kaur et al., 2007
Malathion : In vivo (Swiss albino mice) dos Santos et al., 2016
Cell death (excitotoxic) CPF : In vitro (primary culture) Rush et al., 2010
Cell death (necrotic) Parathion : In vitro (primary culture) Yousefpour et al., 2006
Neuron density CPF
:
In vivo (Swiss albino mice) Mitra et al., 2009*#:
In vivo (Swiss albino mice) Lim et al., 2011*
Cytoarchitecture (2) Axonal Outgrowth CPF
:
In vitro (primary culture) Howard et al., 2005:
In vitro (primary culture) Yang et al., 2008
Dendritic Outgrowth CPF : In vitro (primary culture) Howard et al., 2005
: In vitro (primary culture) Yang et al., 2008
Neurite Outgrowth DZ
:
In vitro (primary culture) Pizzurro et al., 2014a:
In vitro (primary culture) Pizzurro et al., 2014b
Parathion
:
In vitro (primary culture) Yousefpour et al., 2006:
In vitro (primary culture) Berríos et al., 2015
ToCP
:
In vitro (primary culture) Chen et al., 2013
− In vitro (primary culture) Duarte et al., 2016:
In vitro (primary culture) Hausherr et al., 2014
Synaptic Density CPF
:
Ex vivo (C57B1/6J slice culture) Speed et al., 2012
Energy homeostasis (3) ETC DDVP
:
In vivo (Wistar rats) Kaur et al., 2007
Mitochondrial Integrity CPF
:
In vitro (primary culture) Middlemore-Risher et al., 2011
Mitochondrial Activity ToCP
:
In vitro (primary culture) Duarte et al., 2016
Oxidation Pathways DZ : In vitro (primary culture) Pizzurro et al., 2014b
: Isolated synaptosomes (rat) Colovic et al., 2015
DDVP : In vivo (Wistar rats) Kaur et al., 2007
: In vivo (Wistar rats) Binukumar et al., 2010
: In vivo (Wistar rats) Binukumar et al., 2011
Malathion : In vivo (Swiss albino mice) dos Santos et al., 2016
Neurotransmission (4) Axonal transport CPF
:
In vivo (Wistar rats) Terry et al., 2003:
In vivo (Wistar rats) Hernandez et al., 2015
DFP
:
In vitro (primary culture) Gao et al., 2016
Motor proteins CPF
:
Isolated kinesin and microtubules Gearhart et al., 2007:
In vivo (Wistar rats) Prendergast et al., 2007:
Isolated kinesin and microtubules Grigoryan and Lockridge, 2009:
In vitro (primary culture) Middlemore-Risher et al., 2011
DFP
:
Isolated kinesin and microtubules Gearhart et al., 2007:
In vitro (primary culture) Gao et al., 2016
Neuropeptide regulation CPF :
:
In vivo (Long Evans rats) Lee et al., 2016
:
:
In vitro (PC12 cells) Slotkin and Seidler, 2010
DZ :
:
In vitro (PC12 cells) Slotkin and Seidler, 2010
Ca2+ signaling CPF
:
In vitro (PC12 cells) Meijer et al., 2014:
In vitro (PC12 cells) Meijer et al., 2015
Parathion
:
In vitro (PC12 cells) Meijer et al., 2014
ToCP
:
In vitro (primary culture) Hausherr et al., 2016
(Continued)
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TABLE 6 | Continued
Endpoint OP Direction of change Model system Publication
Receptor downregulation CPF
:
In vivo (Sprague-Dawley rats) Huff et al., 2001
DFP
:
In vivo (Long Evans rats) Mundy et al., 1993
MP
:
In vivo (Sprague-Dawley rats) Ma et al., 2003:
In vivo (Sprague-Dawley rats) Sun et al., 2003
Receptor blocking Parathion : In vitro (primary culture) Rocha et al., 1996
Electrophysiology Parathion : In vitro (primary culture) Rocha et al., 1996
CPF : In vivo (Wistar rats) Muller et al., 2014
:
:
Ex vivo (C57B1/6J slice culture) Speed et al., 2012
Signal transduction CPF :
:
In vivo (Wistar rats) Muller et al., 2014
DFP
:
Ex vivo (Wistar rats) Terry et al., 2011
ToCP
:
in vitro (primary culture) Hausherr et al., 2016
Neuroinflammation (5) Cytokine regulation CPF : In vitro (Human fetal astrocytes) Mense et al., 2006
Microglia activation CPF : In vivo (Swiss albino mice) Lim et al., 2011*
DDVP : In vivo (Wistar rats) Binukumar et al., 2011
Malathion : In vivo (Swiss albino mice) dos Santos et al., 2016
Blood brain barrier (6) BBB integrity CPF
:
In vitro (BMEC and primary culture) Parran et al., 2005
Malathion
:
In vitro (RBE4 cells) Balbuena et al., 2010
BBB maintanence
proteins
Malathion
:
In vitro (RBE4 and BMEC cells) Balbuena et al., 2011
*Indicates route of exposure other than SC (topical or tail patch); # Indicates test subjects were female.
PC12, adrenal pheochromocytoma cell line; BBB, blood brain barrier; BMEC, bovine brain microvascular endothelial cell line; CPF, chlorpyrifos; DDVP, dichlorvos; DFP, diisopropyl-
fluorophosphate; DZ, diazinon; ETC, electron transport chain; MP, methyl parathion; RBE4, rat brain microvascular endothelial cell line; ToCP, tri-ortho-cresyl-phosphate.
diazinon-oxon (DZO) that produced 60–90% AChE inhibition.
These results suggest that AChE inhibition does not play an
integral role in cell death. Furthermore, Yousefpour et al. (2006)
observed dose- and time-dependent changes in cell viability, cell
expansion, and cellular morphology of primary hippocampal
cultures following a single exposure to the parathion metabolite,
paraoxon (POX), at 10, 30, 40, 50, 100, and 150 µM. One
week following POX exposure at 30, 40, 50, and 100 µM, cell
viability was significantly reduced, as measured using Neutral
Red (NR) staining, a dye that is normally incorporated into intact
lysosomes of healthy cells (Repetto et al., 2008). Three weeks
after POX exposure, 10 µM concentrations also decreased cell
viability, and both the 30 and 100 µM groups showed cellular
blebbing. The 100 µM group also showed cytoplasmic volume
decrease and increased number of vacuoles, characteristics of
necrotic cell death (Yousefpour et al., 2006). This data was
supported by a later study showing that POX exposure for 6
days at 50, 100, 150, 200, and 300 µM resulted in reduced cell
viability of cultured neural stem and progenitor cells (dNPCs), as
measured by MTT assay and PI (Berríos et al., 2015). Despite 200
µM POX exposures causing 50% AChE inhibition, the authors
concluded that cell viability was unrelated to AChE inhibition,
based on studies using pyridostigmine (PY), a reversible AChE
inhibitor that did not reduce cell viability despite producing the
same degree of AChE inhibition (Berríos et al., 2015).
In vivo OP exposure studies have also demonstrated
cytotoxicity and cell death following repeated exposures. Rats
treated with 6 mg/kg/d DDVP for 12 weeks exhibited activation
of apoptotic pathways, with increases in cytochrome c release
from mitochondria and activation of caspase-3, common
markers of apoptosis (Kaur et al., 2007). Electron microscopy
was used to confirm these findings, revealing characteristic
morphological features of apoptosis in a separate cohort of
exposed rats. In addition, rats exposed to 2.5 mg/kg/d DDVP
for 12 weeks, a dose that produced no significant reductions
in substantia nigra or corpus striatum brain AChE activity,
exhibited 60–70% reductions in dopaminergic neurons of the
substantia nigra (Binukumar et al., 2010). Of note, neuronal
cell loss was not observed in the cortex of exposed animals.
Also, malathion exposure upregulated apoptotic pathways in the
hippocampus in vivo, as measured by expression levels of the
apoptotic signaling proteins Bax and Bak (dos Santos et al.,
2016). Stereological cell counts were not obtained, but choline
acetyltransferase protein expression was unaffected. Thus, the
authors concluded that despite apoptotic pathway activation
there was no neuronal cell loss in the hippocampus.
Aberrant Neuronal Cytoarchitecture
Alterations in the cytoarchitecture or morphology of cells in the
nervous system have been associated with diverse neurological
symptoms. Changes in length, number, or branching patterns of
axons or dendrites have been linked to psychiatric manifestations
in patients, including depression, anxiety, AD, and PD (Marsden,
2013; Rubia et al., 2014; Canu et al., 2015; Negrón-Oyarzo
et al., 2016). Axonal length, neurite length, neurite number,
and dendritic branching in neuronal culture systems have also
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been shown to be altered following exposure to a variety of
OPs, including CPF (Howard et al., 2005; Yang et al., 2008;
Speed et al., 2012), DZ (Pizzurro et al., 2014a,b), parathion
(Yousefpour et al., 2006; Berríos et al., 2015), and TOCP (Chen
et al., 2013; Duarte et al., 2016; Hausherr et al., 2016). For
example, in primary cultures of sympathetic neurons, CPF
inhibited axon outgrowth but promoted dendritic arborization
(Howard et al., 2005). The authors further demonstrated that the
major metabolites of CFP, CPO, and trichloropyridinol (TCP),
similarly have opposing effects on neuronal axons and dendrites.
Specifically, CPO decreased overall axonal outgrowth, while
CPF, CPO, and TCP each independently increased dendritic
outgrowth. These effects were observed at concentrations that did
not inhibit AChE and did not cause cytotoxicity. Furthermore,
sympathetic neurons from superior cervical ganglia are not
cholinergic, so in purified primary cultures the OP-mediated
effect is due to non-cholinergic mechanisms. Further studies
from this same lab examined the mechanism by which CPF
and CPO inhibit axonal growth (Yang et al., 2008). The authors
speculated that because the AChE protein has both enzymatic
and morphogenic properties, CPF could interfere with the latter
to elicit its effects on axonal growth. Sensory neurons cultured
from the dorsal root ganglia of AChE+/+, AChE+/−, and
AChE−/− mice were employed to test this hypothesis. Using
concentrations of CPF and CPO previously reported not to
decrease cell viability or AChE activity, the authors demonstrated
that these compounds only caused deficits in axonal outgrowth
in cultures that expressed intact AChE. It was concluded that
CPF and CPO decrease axonal growth by interfering with the
morphogenic activity of AChE. In support of these findings,
Speed et al. (2012) demonstrated that CPF decreased dendritic
spine density in vivo following 5 days of exposure at 5 mg/kg/d,
levels that inhibited hippocampal AChE by <10% after a single
injection and by approximately 40% after 5 injections. Spine
density was unaffected by CPF exposure when examined 1
week later. However, when spine density was re-examined 3
months after exposure, total spine numbers decreased relative to
controls, which correlated with decreased hippocampal synaptic
transmission (Speed et al., 2012). Although behaviors were not
analyzed directly in these animals, similar dosing paradigms,
as previously described, have produced learning and memory
deficits correlating with these findings. Changes in hippocampal
neuron numbers were not apparent at either the 1-week or
3-month time points. It is well known that morphological
plasticity of both axons and dendrites are critical for the behaviors
discussed above (Leuner and Gould, 2010; Marsden, 2013;
Gipson and Olive, 2016). Therefore, it is possible that these
changes could also occur in occupational OP exposures and
contribute to neurobehavioral deficits.
DZ and its oxidized metabolite DZO also impair neurite
outgrowth (Pizzurro et al., 2014a). Hippocampal neurons
exposed for 24 h to 0.1, 1, and 10 µM DZ and DZO, which
reduced AChE enzymatic activity by 50–80% at the highest
concentrations, exhibited decreased neurite outgrowth in a dose-
dependent manner, while the overall number of neurites per
cell did not change. Concomitantly, indicators of oxidative
stress were also increased with DZ and DZO. Hippocampal
neurons were protected against the effects of DZ and DZO on
neurite outgrowth in the presences of astrocytes, and the authors
demonstrated that this was due to increased glutathione (GSH)
levels (Pizzurro et al., 2014a). An additional study examined
the relationship between hippocampal neurons and astrocytes
following DZ and DZO exposure and found decreased neurite
outgrowth, increased oxidative stress, and protective effects of
astrocytes (Pizzurro et al., 2014b). Briefly, astrocytes were treated
for 24 h with 0.1, 1, and 10 µM DZ and DZO, concentrations
that did not affect cell viability and that reduced AChE activity
by 20% at the highest concentrations of each OP. Hippocampal
neurons cultured for 48 h were inverted on top of the previously
OP-exposed astrocytes, and neurite outgrowth wasmeasured. DZ
and DZO at 10 µM inhibited neurite outgrowth and induced
oxidative stress, as measured by dichlorofluorescein diacetate
(DCF), a fluorescent dye that upon oxidization by reactive oxygen
species (ROS) is converted to a dichlorofluorescein. Furthermore,
astrocytic fibronectin was reduced following DZ and DZO 10
µM exposure, but fibronectin rescued neurite outgrowth deficits.
The authors concluded that the effects on neurite outgrowth
were caused by reductions in astrocytic fibronectin, a key
component of the extracellular matrix crucial for cell adhesion,
and that oxidative stress signals altered the interaction between
hippocampal astrocytes and neurons (Pizzurro et al., 2014b).
Finally, studies have also shown the ability of parathion
and TOCP to induce alterations in cytoarchitecture in vitro.
Yousefpour et al. (2006) reported decreases in the number and
length of neuronal processes in hippocampal primary cells 1 week
after exposure to POX at 30, 40, 50, and 100µM. These data were
supported by an additional study showing that prolonged POX
exposure at 16–66 µM POX indiscriminately decreased neurite
outgrowth in dNPCs, as measured by Scholl analysis (Berríos
et al., 2015). Additionally, TOCP dose-dependently inhibited
neurite outgrowth in SH-SY5Y cells following 24 h treatment
with 200, 500, and 1000 µM, and an autophagy inhibitor
prevented and reversed this growth inhibition, indicating a
critical role for autophagy in TOCP-induced neurite changes
at high doses (Chen et al., 2013). At lower doses (10 µM),
exposure to TOCP for 48 h did not decrease neurite number
or outgrowth in rat primary cortical neurons, as measured by
immunocytochemistry (Duarte et al., 2016). Esterase activity was
also not significantly reduced under these exposure conditions.
Conversely, Hausherr et al. (2014) reported that 10 µM TOCP
exposure for 24 h reduced neurite area and branching in mouse
primary cortical neurons (Hausherr et al., 2014). Differences in
species or methods used to quantify neurites could be responsible
for the discrepancies between these two studies. It is plausible that
the number of neurites in the study by Duarte et al. (2016) were
not affected, but that themorphology was altered. Alternatively, it
is possible that the number of neurons in the study by Hausherr
et al. (2014) was not altered, while the area of each neurite was
reduced. Unfortunately, ChE levels were not examined in some
of these studies, making it difficult to compare results between
the different exposure paradigms.
Aberrant Energy Homeostasis
Cellular metabolism is highly regulated to supply cells with ATP,
and disturbances in energy homeostasis act as signals of cellular
stress that trigger cell death (Tait and Green, 2010). Mitochondria
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are at the crux of energy homeostasis and cellular respiration.
Damage to mitochondrial membrane potential can leave the cell
vulnerable to injury and in some cases trigger apoptosis, while
changes in the citric acid cycle can result in aberrant production
of damaging ROS (Tait and Green, 2010). Mitochondrial
dysfunction has been implicated in neurodegeneration (Migliore
and Coppedè, 2009; McInnes, 2013), and several studies suggest
that both deficiencies in mitochondrial function and oxidative
damage caused by production of abnormal ROS can contribute
to the pathogenesis of AD, PD, and ALS (Lin and Beal, 2006).
DDVP and DZ both elicit deleterious effects on cellular energy
metabolism. For example, mitochondrial energy metabolism was
impaired in rats following 12 weeks of exposure to DDVP
at 6 mg/kg/d, via increasing Ca2+ uptake in mitochondria
and altering important components of the electron transport
chain (ETC), ultimately leading to apoptosis (Kaur et al., 2007).
Although ChE activity was not reported in this study, work
by Verma et al. (2009) using the same DDVP dose exposure
paradigm reported 55% reductions in serum ChE activity and
80% reductions in brain AChE activity. The authors observed
significantly increased Ca2+ uptake in mitochondria isolated
from treated animals, as well as significant decreases in important
enzymes in the ETC (Kaur et al., 2007). Furthermore, critical
mitochondrial antioxidants, such as GSH and mitochondrial
superoxide dismutase (Mn-SOD), were significantly depleted,
while lipid peroxidation and protein oxidation were increased.
The authors also found significant mitochondrial cytochrome
c release and cleaved caspase-3, markers of apoptosis (Kaur
et al., 2007). Exposure to DZ, and to a greater extent its
oxidized metabolite DZO, has also been shown in vitro to
affect energy homeostasis and oxidative stress pathways without
reducing AChE activity. DZ and DZO induced oxidative stress
in hippocampal neuron and astrocyte co-cultures in which
astrocytes were treated for 24 h with 0.1, 1, and 10 µM DZ
and DZO, concentrations that reduce AChE activity by 20%
at the highest concentrations of each OP and did not affect
cell viability (Pizzurro et al., 2014b). DZ and DZO increased
the production of ROS in a concentration-dependent manner,
as measured by DCF. Colovic et al. (2015) also examined
expression levels of antioxidant enzymes, including catalase
(CAT), SOD, and glutathione peroxidase (GPx) following
DZ and DZO exposure. Here, isolated synaptosomes were
exposed to DZ, DZO, and 2-isopropyl-6-methyl-4-pyrimidinol
(IMP), a hydroxylated detoxified DZ metabolite, at increasing
concentrations that did not alter synaptosomal integrity, as
measured by lactate dehydrogenase (LDH) leakage (Colovic
et al., 2015). AChE activity was measured in synaptosomes
following addition of DZ, DZO, and IMP, and inhibition
occurred in a dose-dependent manner with DZO causing the
greatest AChE inhibition at 95%, and the highest concentration
of DZO and IMP not affecting AChE activity. The authors found
that DZ did not significantly alter activity of the antioxidant
enzymes DZO and IMP at levels that affected AChE in entirely
different capacities. However, these agents did induce activity of
antioxidants, suggesting that alterations in antioxidant activity
are not AChE-dependent. Specifically, DZO dose-dependently
induced CAT, GPx, and SOD, while IMP dose-dependently
induced SOD activity (Colovic et al., 2015).
In vivo exposure to DDVP and malathion also alters energy
homeostasis. For example, DDVP induced oxidative stress after
12 weeks of exposure at 2.5 mg/kg/d, without significantly
reducing substantia nigra (SN) or corpus striatum (CS) brain
AChE activity (Binukumar et al., 2010). Significant increases
in ROS levels and lipid peroxidation were also observed, while
NADH dehydrogenase activity and cytochrome oxidase activity
in the SN and CS decreased in exposed rats. Each of these
outcomes indicates oxidative stress. In addition, malathion
exposure decreased NADH dehydrogenase activity, but had no
significant effects on Complex II or Complex IV of the ETC,
following exposures that reduced hippocampal AChE by 0–
40% over 15 days (dos Santos et al., 2016). Deficits in NADH
dehydrogenase activity significantly correlated with observed
deficits in the modified NOR behavioral task.
In addition to altering mitochondrial energy, OPs influence
translocation of mitochondria within the cell. In neurons,
mitochondria travel down the axon to provide energy throughout
the axoplasm from the soma to the synapse. Middlemore-
Risher et al. (2011) demonstrated that CPF and CPO influenced
mitochondrial dynamics in primary cultured rat cortical
neurons. Specifically, cells exposed to CPF and CPO contained
mitochondria that were longer and moved less throughout the
axon. Furthermore, there were significantly fewer mitochondria
per axon in exposed groups. These changes occurred at
concentrations that did not significantly inhibit AChE, as was the
case for CPF, and also at levels that inhibited AChE by 50%, as was
the case for CPO. The authors concluded that there were greater
mitochondrial fusion events and fewer mitochondrial fission
events following CPF exposure (Middlemore-Risher et al., 2011).
In neurons, the balance of mitochondrial fusion and fission is
critical for cell viability. Fission events aid in mitochondrial
distribution within a cell, while fusion events allowmitochondria
to repair and exchange material (Chen and Chan, 2009). It
is interesting that deficits in ATP synthesis or increases in
superoxide production were not observed in this study. Changes
in mitochondrial dynamics could be caused by deficits in axonal
transport, which have been reported following CPF exposure and
are discussed below.
Aberrant Neurotransmission
Since the primary target of OPs is AChE, it is perhaps not
surprising that other aspects of cholinergic signaling are also
affected. For example, a well-established consequence of AChE
inhibition by OPs is down-regulation of postsynaptic muscarinic
acetylcholine receptors, which is thought to play a role in
developing tolerance to chronic OP exposure (Schwab et al.,
1981; Bushnell et al., 1991; Mundy et al., 1993; Stone et al.,
2000; Huff et al., 2001; Ma et al., 2003; Sun et al., 2003;
Costa et al., 2008). However, other OP-induced deficits in
neurotransmission are also observed in vitro. For example, both
DZ and CPF exposure change expression of genes coding for
neuropeptides and their receptors in PC12 cells (Slotkin and
Seidler, 2010). These changes occurred using concentrations that
did not induce overt toxicity (as reported in Jameson et al.,
2007), and were greater in magnitude in differentiating vs.
undifferentiated PC12 cells. Immortalized cell lines, such as PC12
cells, are by necessity less biologically complex than primary
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cultured cells, and also have undergone genetic mutations that
have rendered them immortal. These issues are important to
consider when interpreting the biological effect, and rigorous
verification of findings in immortalized cells should be conducted
in both primary cultures and corresponding intact biological
systems. Thus, it is encouraging that similar observations have
been made using in vivo models of occupational OP exposure.
Lee et al. (2016) found that repeated exposure to 3 and 10
mg/kg/d CPF produced 75–90% cortical AChE inhibition, 40–
80% hippocampal AChE inhibition, and 90–100% whole blood
ChE inhibition, respectively, at the end of a 21-day exposure
period. These exposures induced transcriptomic changes in
genes encoding for hippocampal neuropeptides in animals,
including brain-derived neurotrophic factor (BDNF), cortistatin
(CORT), and neuropeptide Y (NPY). Neuropeptides such as
these are critical neurotransmission signals associated with
diverse neurobehavioral deficits related to AD, PD, exploratory
behavior, and anxiety- and depression-like phenotypes (Cortright
et al., 1995; Heilig, 2004; Moran and Graeber, 2008; Borroni et al.,
2009).
POX also disturbs gamma-Aminobutyric acid (GABA)-
mediated neurotransmission, the major inhibitory
neurotransmitter system in the brain. In cultured hippocampal
cells, POX applied at 0.3–3 µM in the presence of atropine
to block muscarinic receptor overstimulation modified the
frequency of miniature postsynaptic currents (MPCs) without
affecting peak amplitude or decay (Rocha et al., 1996). At
higher concentrations of 30–300 µM, however, POX exposure
reduced frequency, decay times, and peak amplitudes of
GABA-mediated MPCs. Interestingly, POX exposure in the
micromolar range additionally acted as an open-channel blocker,
by noncompetitively and reversibly inhibiting GABAA, glycine,
NMDA, and nicotinic acetylcholine receptors, events that would
be expected to significantly alter neurotransmission within the
brain.
Ca2+ signaling is critical for neurotransmission and neuronal
depolarization events, which contribute to synaptic activity. Ca2+
ions activate ion channels and can act as second messengers in
signal transduction pathways like G-protein coupled receptors.
Thus, even small changes in Ca2+ levels can induce deleterious
effects (Brini et al., 2014). Meijer et al. (2014) reported that
OPs, including CPF and parathion, inhibit depolarization-evoked
intracellular Ca2+ concentrations via voltage-gated calcium
channels (Meijer et al., 2014). These effects occurred in PC12
cells following exposures to CPF and parathion at levels that
did not significantly inhibit purified AChE. CPO, which is a
much more efficient AChE inhibitor, also significantly decreased
depolarization-evoked intracellular Ca2+ concentrations. Effects
on Ca2+ signaling were only partially reversible after 20min.
Furthermore, Meijer et al. (2015) demonstrated that longer
exposures (24 h) and repeated exposures (2 exposures in 24 h)
inhibited voltage-gated calcium channels and depolarization-
evoked intracellular Ca2+ concentrations (Meijer et al., 2015).
Further evidence of cell signaling deficits associated
with prolonged, low to moderate CPF exposure has been
demonstrated in vivo. Muller et al. (2014) observed that repeated
CPF exposure alters rat brain electroencephalograph (EEG), a
measurement that represents the summation of synchronized
electrical currents in the brain. Following 7 days of 0.1, 1,
and 10 mg/kg/d CPF exposure, which inhibits plasma ChE
activity by 0, 50, and 80%, dose-dependent disturbances in EEG
rhythms were detected, first decreasing the power spectra at low
frequencies and then increasing the power spectra at frequencies
higher than 4 Hz. These changes indicate disturbances in
functional connectivity. In addition, somatosensory evoked
potentials (SEPs), which assess the relay of sensory signals from
the periphery to the brain, were altered following this same
exposure paradigm. All doses of CPF decreased the negative
wave amplitudes, while only the highest CPF dose (10 mg/kg/d)
decreased the positive wave amplitude (Muller et al., 2014).
OPs also affect the speed of synaptic transmission. For
example, following 5 days of CPF exposure at 5 mg/kg/d,
levels that inhibited hippocampal AChE by <10% after a single
injection and by approximately 40% after 5 injections, biphasic
change in hippocampal synaptic transmission were detected in
slice cultures (Speed et al., 2012). Initially, synaptic transmission
through the CA3-CA1 region of the hippocampus was increased.
Approximately 3 months later, however, synaptic transmission in
this same region was reduced by 50%. The authors did not report
deficits in neuronal survival but did observe correlation between
the electrophysiological deficits induced by CPF and decreases in
neuronal dendritic spine density (Speed et al., 2012).
Axonal transport comprises movement of critical nutrients,
proteins, and synaptic vesicles between the soma and the axon
terminal, and is a critical aspect of intercellular communication
in the brain. Sciatic nerves harvested from rats exposed to 2.5,
10, 18, or 25 mg/kg/d CPF for 14 days, which exhibited plasma
ChE inhibition from 30 to 60% following a single injection,
showed impaired anterograde and retrograde axonal transport
as measured ex vivo by video-enhanced differential interference
contrast microscopy (AVEC-DIC) (Terry et al., 2003). Deficits in
axonal transport of vesicles persisted for up to 20 days following
the last day of CPF exposure. In addition, MRI studies have
shown that 14-day exposures to 3 and 18 mg/kg/d CPF reduced
brain AChE activity by 60–80% in rats and significantly decreased
axonal transport of Mn2+, both at the end of the exposure period
and after a 30-day washout period (Hernandez et al., 2015).
CPF-induced impairments in axonal transport can partially be
explained by altered motility of mitochondria and changes in
motor proteins like kinesin and microtubules, as well as motor-
associated proteins like tubulin (Gearhart et al., 2007; Prendergast
et al., 2007; Grigoryan and Lockridge, 2009; Middlemore-Risher
et al., 2011). Similar impairments in motor proteins are induced
by DFP exposure, which may also impair axonal transport
(Gearhart et al., 2007; Gao et al., 2016).
Neuroinflammation
Neuroinflammation and immune responses are important
mechanisms of neurotoxicity implicated in OP exposure. Here,
we briefly summarize the existing data regarding the ability
of OPs to modulate neuroinflammation. For a full review on
the effects of OPs on inflammation and immune response (see
Banks and Lein, 2012; Banks, 2015). Repeated administration
of CPF at levels that do not inhibit red blood cell ChE activity
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induces glial fibrillary acidic protein (GFAP) expression in the
mouse hippocampus (Lim et al., 2011). GFAP expression is
commonly associated with gliosis, an inflammatory response of
the brain to neuronal injury that usually results in hypertrophy
or proliferation of glial cells, including astrocytes and microglia.
In vitro evidence further supports these findings, showing that
human fetal astrocytes treated with CPF for 1 week expressed
increased levels of GFAP, IL-6, and other genes associated
with proinflammatory cytokine pathways (Mense et al., 2006).
Malathion exposure that inhibited hippocampal AChE by 40%
also increased GFAP, specifically in the hippocampus (dos Santos
et al., 2016). Likewise, DDVP activates microglia following
repeated exposure in vivo. Animals administered 2.5 mg/kg/d
DDVP for 12 weeks, a dose previously shown to inhibit AChE
by 10–55% (Verma et al., 2009), exhibited microglial activation
preceding neuronal degeneration of cells specifically in the SN
and the CS (Binukumar et al., 2011). The SN and CS are
vulnerable regions in PD and have previously been identified
as targets for DDVP (Binukumar et al., 2010). Activation of
microglia was accompanied by increases in proinflammatory
cytokines and markers of oxidative stress, further indicating
a role for neuroinflammation in DDVP-induced neurotoxicity
(Binukumar et al., 2011). These studies highlight the potential
role of neuroinflammation in the neurotoxicology associated
with OP exposure.
Impairment of the Blood Brain Barrier
In a healthy nervous system, the blood brain barrier (BBB)
is composed of specialized endothelial cells that form tight
junctions to restrict passage of large molecules and most cells
(Saunders et al., 2012). Traumatic brain injury, hypoxia, and
certain chemicals increase BBB permeability. For example, in
an in vitro model of the BBB, the OP malathion and its
metabolite malaoxon decreased BBB integrity, as measured by
transendothelial electrical resistance, following 2-, 4-, 8-, 16-, and
24-h exposures (Balbuena et al., 2010). Malathion and malaoxon
also decreased protein levels of the endothelial tight junction
proteins occludin, claudin-5, ZO1, and ZO2, which are critical
for maintenance of tight junctions in a healthy BBB (Balbuena
et al., 2011). Although ChE inhibition levels were not reported in
this study, previous work using this model showed 20–50%AChE
inhibition (Balbuena et al., 2010), levels comparable to brain
AChE inhibition in previous in vivo reports using other OPs,
such as CPF (Middlemore-Risher et al., 2010), DDVP (Verma
et al., 2009), and DFP (Prendergast et al., 1997). CPF also affects
the integrity of the BBB. Following 24 h exposures to CPF
and CPO that inhibit ChE by 40–100%, bovine microvascular
endothelial cells (BMEC) exhibited significant concentration-
dependent decreases in electrical resistance (Parran et al., 2005).
CONCLUSIONS
Despite increasing research in the field, the effects of repeated
or prolonged OP exposure at low to moderate levels, both
in humans and animal models, remain unclear. Evidence in
humans suggests associations between occupational levels of OP
exposure and deficits in executive function, neuropsychiatric
issues, and neurodegenerative diseases. Effects on learning
and memory in humans are repeatedly observed following
occupational exposures to CPF, but less often examined with
DFP and MP. Studies aimed at examining these types of
exposures in animalmodels also produce ambiguous results. OPs,
including CPF, DFP, and MP, can transiently affect learning and
memory, although conflicting results exist for MP. Furthermore,
malathion exposure disrupts learning and memory, although
the transient nature of these effects has not been explored.
Attention deficits are also often reported in occupational OP
epidemiological studies. In vivo preclinical models demonstrate
clear effects of CPF and DFP on attention and impulsivity
following repeated, low to moderate exposures. These effects
also appear to be transient, but are not consistently supported
by PPI measurements, specifically in the case of DFP exposure.
Disturbances in cytoarchitecture and neurotransmission, as well
as cytotoxicity, could be responsible or contribute to executive
function deficits described in both in vivo rodent studies and in
humans, but causal studies are critically lacking.
Unless acutely toxic exposures are involved, disturbances
in motility are only occasionally described in humans
occupationally exposed to OPs. However, evidence from
in vivo studies suggests that MP, DFP, DDVP, and CPF all
induce transient effects on motility, as measured by open field
locomotion, grip strength, and rotarod. These effects can be
bidirectional, with low doses increasing activity and higher
doses decreasing activity. However, these effects are not without
contention, as some studies do not describe deficits in motility,
specifically with CPF exposure paradigms. Disturbances in
energy homeostasis and neurotransmission could account for
motility deficits, but direct causality for underlying mechanisms
responsible for motility issues should be explored.
In addition, behavioral correlates of affect are often examined
in studies regarding OP exposure, in humans and animals alike.
Epidemiological evidence for occupational OP exposures being
associated with neuropsychiatric issues exists, but this body of
work is problematic to interpret because affect is difficult to
quantify. In vivo studies in preclinical models suggest that CPF,
DFP, and DDVP induce depression-like behavior, as measured
by FST, learned helplessness, novelty suppressed feeding, and
exploratory behavior. Malathion has not been shown to alter
exploratory behavior, but other behavioral paradigms related to
affect have not been employed. Only one study observed changes
in behavior on the EPM, describing increased risky behavior with
higher levels of CPF.
Numerous studies have independently demonstrated the
proclivity of a variety of OPs at lower, prolonged levels to
induce major changes in the central nervous system, including
alterations in gene expression, cell signaling pathways, and
cellular ultrastructure (summarized in Table 6). However, the
majority of these molecular changes have been studied in vitro,
and more studies should be employed to confirm whether
these changes also occur in vivo, as well as to investigate
causality between these mechanisms and neurobehavioral
deficits. Ultimately, each of these molecular disturbances,
together or independently, could contribute to the behavioral
manifestations in animal models discussed here (summarized
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in Table 4), including disturbances in learning and memory,
attention and impulsivity, motor coordination, and depression
and anxiety. These findings have been summarized in Figure 1.
THOUGHTS MOVING FORWARD
The studies presented in this review aid in our understanding of
the effects of repeated, low- to moderate-level OP exposures.
Some important unmet needs in understanding the effects of
occupational OP exposures are:
(1) improvement of methods for quantifying human exposures,
(2) development of more representative biomarkers of
neurotoxicity,
(3) deeper investigation of gene-environment interactions,
(4) inclusion of more females in study design,
(5) broader examination of exposures to mixtures of OPs,
(6) implementation of inhalation studies, and
(7) more studies to address the longitudinal effects of early-life
exposures.
With respect to (1) and (2), AChE inhibition levels are currently
used as a common measurement in animal studies to describe
OP exposure. However, it is clear that AChE is inhibited
to varying extents depending on animal or cell model, dose,
duration of exposure, and specific OP. Although many of
the studies presented here do not produce cholinergic crisis,
despite having large reductions in ChE activity, significant but
variable effects can be seen. New biomarkers of exposures and
methods of identifying the extent of toxicity following these
types of exposures need to be developed in order to accurately
compare studies and draw valid conclusions regarding the
effects of occupational OP exposures. Development of these new
biomarkers would aid in improving our ability to standardize
comparison of results from both in vivo and in vitro studies. In
addition, application of a standardized behavioral test battery
that measures an array of functional endpoints in future OP
animal studies could also help facilitate comparisons between
species, OPs, and varying exposure paradigms. In human studies,
AChE inhibition is commonly used as a biomarker of effect,
while urinary metabolite measurements are generally used as
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FIGURE 1 | Summary of neurotoxic effects in experimental models of occupational OP exposures. Molecular manifestations are summarized on the left with
normal physiological conditions in the black box and OP-induced effects in the red box. Numbers in the lower box correspond to numbers for specific endpoints
identified in Table 6. Behavioral outcomes identified in animal models of occupational OP exposure are summarized on the right with black lines indicating normal
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biomarkers of exposure. These measurements aid comparison of
exposures across human studies, and new research is currently
underway to identify and develop novel biomarkers of both
exposure and effect.
With respect to (3), gene-environment interactions should
be explored in regards to occupational OP exposures, as
they are implicated in the etiology of nearly all diseases. PD
is a great example of the importance of gene-environment
interactions in disease development. For example, α-synuclein
accumulation, a pathological hallmark of PD, is notoriously
affected by chemicals that increase ROS (Ross and Smith,
2007). Furthermore, OPs are more strongly associated with PD
in patients with certain genetic variations in paraoxonase 1
(PON1), aldehyde dehydrogenase (ALDH2), and nitric oxide
synthase (NOS1) (Benmoyal-Segal et al., 2005; Fitzmaurice et al.,
2014; Paul et al., 2016). Accordingly, it is critical to pursue
research that considers the potential for gene-environment
interactions in the neurotoxicity associated with OPs. Recent
development of the CRISPR Cas9 system has made genetic
modeling easier and quicker than ever before (Hsu et al., 2014).
Implementation of this system in studying gene-environment
interactions would greatly improve our understanding of
how OP chemicals interact with specific genes and cellular
pathways.
With respect to (4), (5), and (6), studies could more accurately
and completely depict repeated low to moderate OP exposures
in the workplace by including females, examining OP mixtures,
and employing inhalation exposure paradigms. First, one gap
in research identified through this review is understanding
the effects of exposure to OP chemicals across sexes. Little is
known about the effects of OPs in males vs. females (Karalliedde
et al., 2003). However, certain characteristics of females may
provide protection from toxicities associated with OP exposures,
or alternatively render them more vulnerable to exposure. For
example, females have higher paraoxonase activity (Costa et al.,
2005), which is a primary OP detoxifying enzyme, and therefore
may be protected from certain OP exposures. Alternatively,
pregnant women pose a different concern for occupational
exposure hazards, as developing fetuses are particularly at risk
for adverse effects following OP exposures (Eskenazi et al., 2008).
Unfortunately, as noted in Table 2, there are only two studies
that met inclusion criteria for this review that investigated the
effects of OPs in females, neither of which investigated behavioral
endpoints. Furthermore, none of the studies compared sexes to
determine whether sex differences in neurotoxic responses to
OPs exist. According to the Food and Agriculture organization
of the United Nations (FAO), women make up roughly 43%
of the global agricultural workforce, and should therefore also
be considered in these studies (FAO, 2010). In some countries,
it is even common for a pregnant woman to work until the
time she gives birth, and then to almost immediately return
to work. While epidemiological studies have focused on the
effects of these occupational exposures on children and identified
correlations with ADHD, autism, and developmental disorders
(Miodovnik, 2011; Burns et al., 2013), comparatively little is
understood about the effects women themselves endure. It is
imperative that more research be completed in females in order
to begin to understand the effects of these exposures across
sexes.
With specific reference to (5), both in vivo and in vitro
studies should explore the effects of OP mixtures. Occupational
exposures are rarely limited to a single OP, and it is possible
for exposure to multiple OPs and other pesticides to have
additive or synergistic effects. For example, toxicity associated
with exposure to malathion was exacerbated when occurring
concomitantly with carboxylesterases (CaEs) inhibitor exposure
(Casida and Sanderson, 1961; Cohen and Murphy, 1971a,b;
Verschoyle et al., 1982). Also, del-Rahman et al. (2004) reported
greater-than additive effects of malathion when mixed with
additional pesticides. In this review, only one study examined
the effects of chemical mixtures, but it included an OP and
organochlorine mixture, not multiple OPs.
With specific reference to (6), the purpose of this review is
to examine the models used to study occupational exposures to
OPs and the results pertaining to the effects of these exposures,
specifically on the nervous system. We carefully selected studies
that we believe best replicate human occupational exposures to
OPs. In doing so, we restricted our discussion to models of
prolonged dermal exposure at sub-cholinergic crisis levels to
study the effects of these chemicals on neurologic endpoints.
We believe exposure paradigms using topical application or
subcutaneous injections best replicate the exposure parameters
generally experienced by humans who are occupationally
exposed to OPs. These exposure methods ensure a prolonged,
systemic exposure that represents dermal exposure, the primary
route in occupational settings. Another important exposure route
in the occupational setting, however, is inhalation, specifically in
reference to TOCP exposures in airplane-associated occupations
(de Ree et al., 2014). More research into the effects of
inhalation exposure is warranted due to increasing awareness
for an aerotoxic syndrome among airline crewmembers, a
syndrome that produces headaches, dizziness, confusion, muscle
weakness, and neurobehavioral problems (de Ree et al., 2014).
Unfortunately, few studies have investigated the effects of
inhalation exposure to OPs on the nervous system. Therefore,
we could not include them in this review. Recent improvements
in inhalation and aerosolization equipment provide scientists
with the opportunity to answer questions about the effects
of inhaling OPs. There is a need for future studies directed
toward understanding both the in vivo and in vitro effects of
inhalation/aerosolization of OPs on the nervous system.
Finally, with respect to (7), the long-term effects of
occupational OP exposures have not been heavily investigated
in humans, but lasting neurological impairment has been
reported (Jamal, 1997; Rohlman et al., 2016). Moreover, very few
studies have examined the lasting effects of repeated, low- or
moderate-level exposures in experimental models. In vivo studies
examining long-term effects of occupational OP exposures
included in this analysis demonstrated the transient nature
of deficits induced by OPs on neurobehavior. Interestingly,
however, hippocampal electrophysiology, dendritic outgrowth,
and axonal transport ofMn2+ were alteredmonths after exposure
to CPF, but this does not correlate with the transient behavioral
deficits observed in vivo. The potential for these molecular
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changes to cause long-term effects certainly warrants further
investigation.
Since occupational exposures to OPs are common, and
workers represent the most at-risk population for OP-associated
side effects, research focused on the adverse health effects is
crucial. Although the evidence linking occupational exposure
to neurotoxic outcomes is contradictory, animal studies that
aim to simulate exposure durations and levels consistent
with occupational exposures indicate that these OP exposures
induce neurologic sequelae. Furthermore, studies in vitro are
starting to illuminate potential mechanisms by which OPs cause
neurobehavioral deficits, which may inform animal and human
studies. Ultimately, more research pertaining to occupational OP
exposures is necessary to determine safe exposure levels, refine
protection methods, establish treatment strategies, and improve
workplace conditions globally.
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